- Home
- BCBP vs CRDF Comparison
BCBP vs CRDF Comparison
Compare BCBP & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- CRDF
- Stock Information
- Founded
- BCBP 2000
- CRDF 1999
- Country
- BCBP United States
- CRDF United States
- Employees
- BCBP N/A
- CRDF N/A
- Industry
- BCBP Savings Institutions
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCBP Finance
- CRDF Health Care
- Exchange
- BCBP Nasdaq
- CRDF Nasdaq
- Market Cap
- BCBP 136.5M
- CRDF 152.3M
- IPO Year
- BCBP N/A
- CRDF N/A
- Fundamental
- Price
- BCBP $7.70
- CRDF $2.16
- Analyst Decision
- BCBP Hold
- CRDF Strong Buy
- Analyst Count
- BCBP 2
- CRDF 4
- Target Price
- BCBP $9.25
- CRDF $10.63
- AVG Volume (30 Days)
- BCBP 81.0K
- CRDF 712.2K
- Earning Date
- BCBP 10-27-2025
- CRDF 11-06-2025
- Dividend Yield
- BCBP 8.33%
- CRDF N/A
- EPS Growth
- BCBP N/A
- CRDF N/A
- EPS
- BCBP 0.05
- CRDF N/A
- Revenue
- BCBP $64,592,000.00
- CRDF $501,000.00
- Revenue This Year
- BCBP $23.06
- CRDF N/A
- Revenue Next Year
- BCBP $3.55
- CRDF N/A
- P/E Ratio
- BCBP $154.30
- CRDF N/A
- Revenue Growth
- BCBP N/A
- CRDF N/A
- 52 Week Low
- BCBP $7.54
- CRDF $1.90
- 52 Week High
- BCBP $14.04
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- BCBP 38.87
- CRDF 42.90
- Support Level
- BCBP $7.61
- CRDF $2.06
- Resistance Level
- BCBP $7.89
- CRDF $2.33
- Average True Range (ATR)
- BCBP 0.18
- CRDF 0.11
- MACD
- BCBP -0.00
- CRDF -0.01
- Stochastic Oscillator
- BCBP 9.41
- CRDF 21.88
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.